Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Intensive Care"
DOI: 10.1186/s40560-020-00491-y
Abstract: A high rate of thrombotic complications, such as pulmonary embolism, has been linked to mortality in COVID-19, and appropriate treatment of thrombosis is important for lifesaving. Although heparin is frequently used to treat thrombotic pathology… read more here.
Keywords: suppressed fibrinolytic; fibrinolytic therapy; pathology; covid ... See more keywords